November 3, 2023 Sophia Vida
Breaking News

BioStem Technologies Closes Oversubscribed $2M Private Placement

POMPANO BEACH, FLORIDA, November 3, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has closed an oversubscribed private placement of common stock to accredited investors for an aggregate of 1,337,000 units (each, … Continue reading “BioStem Technologies Closes Oversubscribed $2M Private Placement”